ADA and neoplasm: Prior studies in infectious organisms, and a very limited number of tumor types, suggested that ADA also recognizes 3′-deoxyadenosine/cordycepin and converts it to 3′-deoxy-inosine, inhibiting its therapeutic effects [21,22,23].